QIAGEN Launches New Secondary Analysis Solution for Oncology and Inherited Disease

QIAGEN Launches New Secondary Analysis Solution for Oncology and Inherited Disease

By, Admin 6 May 2024

QIAGEN Launches New Secondary Analysis Solution Tailored for Oncology and Inherited Disease Bioinformatics Workflows

Overview

QIAGEN has introduced QCI Secondary Analysis, a cloud-based software-as-a-service (SaaS) solution that facilitates high-throughput secondary analysis for clinical next-generation sequencing (NGS) data. This platform seamlessly integrates with QCI Interpret, QIAGEN's clinical variant interpretation and reporting software, and supports all QIAGEN QIAseq panels.

Sequencing Data

  • Traditionally, sequencing data goes through three phases: primary analysis, secondary analysis, and tertiary analysis. 
  • QCI Secondary Analysis focuses on the secondary analysis stage, where DNA fragments are assembled and analyzed for variants in relation to a reference genome. 
  • This tool simplifies the bioinformatics pipeline, making NGS testing more accessible to labs of varying sizes and expertise levels.
  • The platform is designed to streamline analysis from various assay types, minimizing resource investment while maximizing productivity. 
  • It is deployed on the secure QIAGEN Clinical Cloud, ensuring data protection and compliance with regulatory standards such as ISO 27001, GDPR, and HIPAA.

Support for QIAseq Panels

  • QCI Secondary Analysis complements QIAGEN's Sample to Insight portfolio, providing validated support for QIAseq panels, integration with QCI Interpret, and compatibility with other QIAGEN software modules like LightSpeed Clinical. 
  • QIAGEN Digital Insights solutions empower researchers and clinicians worldwide, facilitating data processing and interpretation for improved research outcomes.

QCI Secondary Analysis

  • For labs interested in leveraging comprehensive genomic information, QCI Secondary Analysis offers a user-friendly, turnkey solution. 
  • With its ability to process more sequencing data efficiently, this platform represents a significant advancement in precision medicine accessibility.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!